Perthera guides advanced-stage cancer patients and their physicians to the best-in-class personalized cancer treatment options available by bridging the gap between molecular testing and patient therapy.
Our unique approach uses the most advanced molecular diagnostic testing to create a detailed analysis of a patient’s unique cancer. Perthera’s proprietary Expert Oncology Platform, ExpO, combines that analysis with the patient’s medical history and generates a comprehensive PrecisOn analysis. Our dedicated medical panel reviews the analysis and makes recommendations based on the latest cancer treatment options available. Our MRP comprises industry oncology experts, practicing clinicians and disease-relevant scientists. We are not a lab; we are an oncology solutions service empowering oncologists at the point of care with improved physician decision-making and optimized therapy options unique for each patient.
For more information, visit their website here.